Geneos Wealth Management’s Luminex Corp LMNX Stock Holding History

Geneos Wealth Management’s Portfolio LMNX Stock Details LMNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-311	Closed	-$9K	–	3164
2020 Q4	$9K	Buy	+311	New	+$7.23K	﹤0.01%	2282

Other funds holding LMNX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Geneos Wealth Management's LMNX Position: Q1 2021 in Review

Geneos Wealth Management sold out of Luminex Corp (LMNX) in Q1 2021, closing a stake of 311 shares — an estimated $9K sold.

Geneos Wealth Management first reported a position in LMNX in Q4 2020 and held it in 1 quarter. The position peaked at $9K in Q4 2020. 213 funds tracked by Wall St. Rank hold LMNX as of Q1 2021.

Geneos Wealth Management reported no remaining Luminex Corp position as of Q1 2021 after selling out during the quarter.
Geneos Wealth Management sold 311 Luminex Corp shares in Q1 2021, an estimated $9K.
Geneos Wealth Management first reported a position in Luminex Corp in Q4 2020 and held it in 1 quarter.
Geneos Wealth Management's Luminex Corp position peaked at $9K in Q4 2020.
213 funds tracked by Wall St. Rank held Luminex Corp as of Q1 2021.

Based on Geneos Wealth Management's 13F filing for Q1 2021, filed 17 Jun 2021.